Author: Norman F. Billups
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
American Drug Index 1999
Author: Norman F. Billups
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
American Pharmacy (1852-2002)
Author: Gregory Higby
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292392
Category : Medical
Languages : en
Pages : 148
Book Description
Essays reprinted from the Journal of the American Pharmaceutical Association series commemorating the sesquicentennial of the American Pharmaceutical Association.
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292392
Category : Medical
Languages : en
Pages : 148
Book Description
Essays reprinted from the Journal of the American Pharmaceutical Association series commemorating the sesquicentennial of the American Pharmaceutical Association.
Psychologists' Psychotropic Drug Reference
Author: Louis A. Pagliaro
Publisher: Psychology Press
ISBN: 9780876309643
Category : Medical
Languages : en
Pages : 732
Book Description
This volume traces the modern critical and performance history of this play, one of Shakespeare's most-loved and most-performed comedies. The essay focus on such modern concerns as feminism, deconstruction, textual theory, and queer theory.
Publisher: Psychology Press
ISBN: 9780876309643
Category : Medical
Languages : en
Pages : 732
Book Description
This volume traces the modern critical and performance history of this play, one of Shakespeare's most-loved and most-performed comedies. The essay focus on such modern concerns as feminism, deconstruction, textual theory, and queer theory.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
The Drug Legalization Debate
Author: James A. Inciardi
Publisher: SAGE
ISBN: 9780761906902
Category : Law
Languages : en
Pages : 196
Book Description
This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.
Publisher: SAGE
ISBN: 9780761906902
Category : Law
Languages : en
Pages : 196
Book Description
This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
American Drug Index
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1160
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 1160
Book Description
History of Drug Containers and Their Labels
Author: George B. Griffenhagen
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Book Description
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Book Description
United States and International Drug Control, 1909-1997
Author: David R. Bewley-Taylor
Publisher: A&C Black
ISBN: 9780826458131
Category : Political Science
Languages : en
Pages : 264
Book Description
The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.
Publisher: A&C Black
ISBN: 9780826458131
Category : Political Science
Languages : en
Pages : 264
Book Description
The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.
Martindale
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced